drugset / Trial / NCT00002383
A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients
Treatment
Summary
To compare the antiviral activity, safety, and pharmacokinetics of saquinavir hard gel capsule (HGC) formulation, to 1 of 3 doses of saquinavir soft gel capsule (SGC) formulation administered orally every 8 hours for 4 weeks.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Saquinavir | Small molecule | 400 mg | Oral |
| Subject | Saquinavir | Small molecule | 600 mg | Oral |
| Subject | Saquinavir | Small molecule | 800 mg | Oral |
| Subject | Saquinavir | Small molecule | 1200 mg | Oral |